Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Nuvation Bio Inc. is a biopharmaceutical company focused on developing innovative oncology therapies. Its core activities include discovering, developing, and commercializing targeted small molecules and drug conjugates for cancer treatment. The company’s pipeline features advanced candidates like taletrectinib for ROS1+ lung cancer and safusidenib for mIDH1 glioma, leveraging proprietary chemistry and strategic licensing to address unmet medical needs globally.
This description was generated via AI from an annual report. Updated about 1 year ago.